Get started
Author

Kim M. Stegmann

Observed names: Kim Stegmann, Kim-Maren Stegmann, Stegmann, Kim Maren
ORCID: 0000-0001-8099-708X
Observed ORCID: 0000-0001-8099-708X
OpenAlex ID: A5068776922
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
2021 · Thomas Güttler, Metin Aksu, et al. · The EMBO Journal · 98
PDF
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
2021 · Kim M. Stegmann, Antje Dickmanns, et al. · Virus Research · 50
PDF
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
2022 · Kim M. Stegmann, Antje Dickmanns, et al. · iScience · 39
PDF
Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design
2024 · Lisa-Marie Funk, Gereon Poschmann, et al. · Nature Communications · 29
PDF
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
2023 · Metin Aksu, Priya Kumar, et al. · Antiviral Research · 28
PDF
N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody
2023 · Arne Zibat, Xiaoxiao Zhang, et al. · iScience · 17
N4-Hydroxycytidine and Inhibitors of Dihydroorotate Dehydrogenase Synergistically Suppress SARS-CoV-2 Replication
2022 · Kim M. Stegmann, Antje Dickmanns, et al. · SSRN Electronic Journal · 8
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication
2025 · Doha Al Krad, Kim M. Stegmann, et al. · Antiviral Research · 4
Centrosome impairment causes DNA replication stress through MLK3/MK2 signaling and R-loop formation
2020 · Zainab Tayeh, Kim Stegmann, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replication
2025 · Leon Schrell, David Scheibner, et al. · Antiviral Research · 2
Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry
2024 · Krzysztof Urbanowicz, Mikolaj Opielka, et al. · Nucleosides Nucleotides & Nucleic Acids · 2
PDF
Redox regulation of the SARS-CoV-2 main protease provides new opportunities for drug design
2022 · Lisa-Marie Funk, Gereon Poschmann, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N4-hydroxycytidine and inhibitors of CTP synthetase in cell culture
2025 · Kim M. Stegmann, Antje Dickmanns, et al. · Virology · 1
Synergistic interference with SARS-CoV-2 replication by Molnupiravir-derived N4 hydroxycytidine and inhibitors of CTP synthetase
2025 · Kim M. Stegmann, Antje Dickmanns, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Interfering with critical steps of the viral replication cycle to diminish SARS-CoV-2 propagation
2022 · Stegmann, Kim Maren
Works count: 15
Citation count: 283
H-index: 7
I10-index: 6
Year
Topic
Type